Kiran Philip

About Kiran Philip

Innovative Pharmaceutical Industry Leader:25+ years experience driving innovation and patient-centric solutions across the drug development and commercialization spectrum.Comprehensive Therapeutic Expertise:Deep knowledge and leadership experience particularly in Cardiovascular, Diabetes, Obesity, and Renal areas.Cross-Functional Industry Leadership:Proven success in various pharmaceutical functions: Medical Affairs, Clinical Development, Marketing, Business Development, Corporate Strategy, and Corporate Venture Capital.Global Perspective:Extensive experience in both U.S. and global roles, including North America, European Union, JAPAC, and Emerging Markets.Medical Affairs Excellence:Championed global and U.S. medical strategies, generating compelling scientific evidence and impactful communication campaigns. Extensive expertise in launch, marketed, and pipeline assets. Instrumental in multiple blockbuster product launches in US and global markets. Recognized for leveraging scientific insights to drive business outcomes, pioneering digital engagement strategies, and cultivating influential partnerships with healthcare providers, patient advocates, and payers.Clinical Development Expertise:Over a decade steering global clinical research programs encompassing patients across 50+ nations. Orchestrated studies from Phase I to large-scale outcomes trials, while successfully navigating complex regulatory landscapes from IND submissions to FDA Advisory Committee presentations. Business Development Acumen:Spearheaded global asset evaluation and acquisition strategies, resulting in several high-impact licensing deals and acquisitions valued at billions of dollars. Proficient in assessing opportunities from preclinical through commercial stages.AI and Digital Health Pioneer:Dedicated to integrating AI into the pharma/biotech field. Holds multiple post-graduate certifications from Stanford, MIT, and Oxford in AI healthcare applications. Skilled in utilizing AI for drug discovery, clinical trial optimization, and precision medicine. Expertise includes AI strategy development, ethical implementation, and governance within the life sciences sector.Executive Leadership:Demonstrated ability to lead and transform teams across varied settings, including top-tier pharmaceutical companies (Amgen, Takeda, Abbott, Abbvie), and renowned hospitals (Cleveland Clinic, Cedars-Sinai).Driven by a commitment to advancing patient care through clinical expertise, scientific rigor, business acumen, and technological innovation.

Experience

1. Global Medical Lead, Cardiovascular

   Amgen

   Jan 2018 — Present

   Global Medical Lead, Olpasiran (Lp(a) program)(2019 - present)Global Medical Lead, Cardiovascular/Metabolic Pipeline (20••••22)Global Medical Lead, Repatha (20••••20)• Provide strategic and scientific leadership to the Repatha and CV/Metabolic pipeline assets by leading the cross functional global medical affairs team to develop the global medical strategy • Represent medical affairs at various global leadership forums including Global Product Team, Global Evidence Generation Team and Global Marketing Team• Accountable for strategic oversight of all medical affairs activities across regions and partnering with regional teams to track key milestones• Develop and lead the execution of global medical affairs strategy, including external stakeholder management, communication, evidence generation, insights generation, and medical education • Develop and lead the execution of a global medical communication strategy, including clinical narrative framework, scientific platform, core content, congresses, and publications • Develop and lead global external stakeholder engagement strategy (HCPs, payers, medical societies) to strengthen understanding of the unmet need and medical value• Partner with Value & Access and Evidence Generation teams to define and prioritize TA-specific evidence gaps, develop and implement evidence generation strategy• Provide medical oversight of prospective and retrospective observational studies, comparative effectiveness research, chart reviews, registry trials, and other evidence generation projects

Education

• University of Kerala

  MBBS, Medicine

  1991 — 1998

• University of California, San Francisco

  Diploma, Pharmaceutical Medicine

  2010 — 2012

• University of Kerala

  MBBS, Clinical Research Fellow

  1998 — 2001

• Cleveland Clinic

  Residency, Internal Medicine

  2003 — 2006

• Northwestern University - Kellogg School of Management

  MBA

  2011 — 2014

• UCLA

  Fellowship, Cardiology

  2007 — 2010

• University of Pennsylvania

  Post Doctoral Research Fellow

  2002 — 2002

Skills

• Medical Affairs
• Endocrinology
• Medicine
• Pharmaceutical Industry
• Fda
• Hypertension
• Pharmaceuticals
• Diabetes Mellitus
• Portfolio Planning
• Lipid Disorders
• Cardiology
• Translational Medicine
• Brand Management
• Pharmacovigilance
• Licensing
• CRO
• Clinical Trials
• Clinical Research
• Clinical Pharmacology
• Diabetes
• Regenerative Medicine
• Healthcare
• Business Development
• Neurology
• Product Development
• Biomarkers
• Clinical Operations
• Heart Failure
• R & D
• Pharmaceutical Strategy
• Rheumatology
• New Product Development
• Biotechnology
• Stem Cells
• Atherosclerosis
• Pharmaceutics
• Drug Discovery
• Internal Medicine
• Therapeutic Areas
• Pharmacology